Larvol Delta - ASLAN-Pharmaceuticals-Announces-LateBreaker-Presentation-of-Data-From-Eblasakimab-ProofofConcept-Study-at-the-2022-American-Academy-of-Dermatology-Annual-Meeting

eblasakimab (ASLAN004) - ASLAN Pharma

https://www.globenewswire.com/news-release/2022/03/28/2410845/0/en/ASLAN-Pharmaceuticals-Announces-Late-Breaker-Presentation-of-Data-From-Eblasakimab-Proof-of-Concept-Study-at-the-2022-American-Academy-of-Dermatology-Annual-Meeting.html

Apr 1, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next